Molecular Residual Disease Monitoring Provides Insufficient Lead-Time to Prevent Morphologic Relapse in the Majority of Patients with Core-Binding Factor AML

被引:1
作者
Puckrin, Robert [1 ]
Atenafu, Eshetu G. [2 ]
Claudio, Jaime [2 ]
Chan, Steven M. [3 ]
Gupta, Vikas [2 ]
Maze, Dawn [4 ]
McNamara, Caroline J. [2 ]
Minden, Mark D. [2 ]
Schuh, Andre [2 ]
Murphy, Tracy [2 ]
Sibai, Hassan [2 ]
Yee, Karen W. L. [2 ]
Stockley, Tracy L. [5 ]
Kamel-Reid, Suzanne [5 ]
Schimmer, Aaron D. [2 ]
机构
[1] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
[2] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Univ Toronto, Toronto, ON, Canada
[5] Princess Margaret Canc Ctr, Adv Mol Diagnost Lab, Toronto, ON, Canada
关键词
D O I
10.1182/blood-2018-99-113090
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
436
引用
收藏
页数:3
相关论文
empty
未找到相关数据